No Data
No Data
Merck Stops Lung Cancer Study For Keytruda Combo Due To Ineffective Results, Side Effects
Looking Into Merck & Co's Recent Short Interest
Merck Ends Trial Evaluating Lung Cancer Treatment Following Committee Recommendation
Merck Halts Phase 3 Trial of Lung Cancer Combination Therapy
Merck Lung Cancer Combo Therapy Fails in Phase 3 Trial
Merck Says It's Discontinuing a Late-stage Trial of a Lung Cancer Treatment After High Number of Adverse Events
No Data